Search for: "ELI LILLY V TEVA PHARMA"
Results 21 - 40
of 105
Sorted by Relevance
|
Sort by Date
31 Aug 2010, 10:01 pm
: Sanofi-Aventis v FDA, Sandoz (FDA Law Blog) (GenericsWeb) Mirapex (Pramipexole) – US: Mirapex case ends, Mylan Found to infringe Boehringer patent (Patent Docs) Moviprep (Polyethylene glycol) – US: Salix settles with Novel over Moviprep (IPBiz) Norvir (Ritonavir) – US: PUBPAT challenges eight of Abbott’s HIV/AIDS medicine patents (IP Watch) Strattera (Atomoxetine) – US: Eli Lilly granted 14-day injunction prohibiting production of generic… [read post]
2 Jul 2007, 2:51 pm
Kali Labs (settled) Prozac Weekly: Eli Lilly v. [read post]
18 Aug 2010, 12:19 am
(Patent Baristas) Strattera (Atomoxetine) – US: District Court rules against Lilly regarding Strattera patent: Eli Lilly v Actavis Elizabeth (GenericsWeb) Vigamox (Moxifloxacin) – US: Alcon denied permanent injunction against Teva in Vigamox litigation (Patent Docs) [read post]
27 Feb 2009, 5:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Evista (Raloxifene) – US: CAFC affirms extension of 30-month stay against Teva’s generic Evista: Eli Lilly & Co v Teva Pharmas. [read post]
3 Nov 2010, 1:21 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
21 Nov 2008, 11:36 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
12 Oct 2010, 8:56 pm
Highlights this week included: Aricept(Donepezil) –US: Declaratory judgment jurisdiction for subsequent Paragraph IV filers: Teva Pharmaceuticals USA, Inc. v. [read post]
24 Mar 2010, 4:45 am
Eli Lilly & Co. [read post]
11 May 2011, 4:54 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
10 Aug 2010, 8:44 pm
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
18 May 2011, 12:33 am
Highlights this week included: US: FTC alleges companies were asleep at the wheel when they failed to report settlement agreements on Ambien CR; Commission uses the opportunity to provide industry guidance – and a warning (FDA Law Blog) (GenericsWeb) Gemzar (Gemcitabine) – US: Certiorari denied in Eli Lilly v. [read post]
9 Apr 2009, 7:52 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
16 Dec 2009, 3:39 am
Eli Lilly & Co. [read post]
28 Sep 2010, 3:14 pm
Eli Lilly & Co. [read post]
1 May 2009, 9:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Zometa (Zoledronic acid) – US: Teva and Novartis settle patent dispute over Zometa (Patent Docs) Zyprexa (Olanzapine) – Canada: Patent Act contains no reference to invalid selection patents: Eli Lilly v Novopharm (Patent Baristas) [read post]
9 May 2022, 12:06 pm
Citing the Federal Circuit’s decision in Eli Lilly & Co. v. [read post]
9 May 2022, 12:06 pm
Citing the Federal Circuit’s decision in Eli Lilly & Co. v. [read post]
9 May 2022, 12:06 pm
Citing the Federal Circuit’s decision in Eli Lilly & Co. v. [read post]
15 Sep 2010, 2:40 am
Here is Think IP Strategy’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
